Industry: Health care Region: Germany Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A German company is the world's leading medical technology company and the leader of cardiac and intravascular medical technology, headquartered in Berlin. The goal is to improve patients' health by developing brand-new, tailored and highly reliable cardiology therapy. Innovative products and remote monitoring services such as pacemakers, stents and implantable defibrillators for heart and life have entered the markets of many countries or regions.
Product introduction:
1. Heart rhythm management
The product portfolio includes implantable devices, electrodes and accessories to treat and manage arrhythmia-related diseases. Specially designed implantable devices include products for bradycardia (pacemakers), products for tachycardia (implantable defibrillators) and resynchronization therapy for heart failure.
2. Electrophysiology
Advanced solutions to diagnose and treat patients with arrhythmia.
3. Vascular intervention
The products of this product line are mainly used for coronary artery and peripheral narrow or occluded blood vessels to restore blood flow. Provide a variety of stent systems, balloon catheters and guide wires for patients with coronary artery and peripheral artery diseases.
4. Neuroregulation
Using advanced spinal cord stimulation system, the product aims to improve the care of patients with chronic intractable pain, and at the same time reduce the burden on clinicians, nurses and patients.
Cooperation mode:
Looking for partners who need cardiac and vascular medical technical services.